Quest Diagnostics Incorporated
DGX
$234.40
-$1.64-0.70%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.21% | 9.16% | 7.06% | 13.18% | 15.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.21% | 9.16% | 7.06% | 13.18% | 15.19% |
| Cost of Revenue | 10.90% | 9.42% | 7.87% | 11.54% | 14.35% |
| Gross Profit | 8.90% | 8.63% | 5.41% | 16.54% | 16.83% |
| SG&A Expenses | 9.58% | 7.56% | 6.35% | 13.66% | 18.23% |
| Depreciation & Amortization | -2.56% | -5.13% | 0.00% | 21.88% | 34.48% |
| Other Operating Expenses | -- | -- | -100.00% | 200.00% | -300.00% |
| Total Operating Expenses | 10.50% | 8.71% | 7.34% | 12.22% | 15.26% |
| Operating Income | 8.67% | 11.99% | 5.38% | 18.98% | 14.78% |
| Income Before Tax | 7.38% | 14.97% | 10.86% | 11.26% | 25.16% |
| Income Tax Expenses | -9.28% | 25.42% | 19.12% | 18.46% | 31.08% |
| Earnings from Continuing Operations | 12.84% | 12.34% | 8.47% | 9.28% | 23.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 20.00% | 21.43% | -27.27% | -27.27% |
| Net Income | 13.48% | 14.55% | 10.36% | 8.41% | 23.14% |
| EBIT | 8.67% | 11.99% | 5.38% | 18.98% | 14.78% |
| EBITDA | 7.02% | 10.06% | 5.92% | 17.57% | 16.56% |
| EPS Basic | 14.55% | 15.65% | 11.36% | 8.00% | 22.14% |
| Normalized Basic EPS | 13.85% | 14.71% | 13.10% | 16.09% | 13.40% |
| EPS Diluted | 14.98% | 15.46% | 10.97% | 8.54% | 21.67% |
| Normalized Diluted EPS | 13.83% | 14.69% | 14.11% | 16.10% | 13.41% |
| Average Basic Shares Outstanding | -0.89% | -0.90% | 0.00% | 0.00% | 0.90% |
| Average Diluted Shares Outstanding | -0.88% | -0.88% | -0.88% | 0.00% | 0.89% |
| Dividend Per Share | 7.50% | 7.50% | 6.67% | 6.67% | 6.67% |
| Payout Ratio | -0.06% | -0.09% | -0.03% | -0.02% | -0.13% |